Online pharmacy and digital healthcare venture 1mg today acquired MediAngels, the platform for super-speciality consultations and corporate healthcare. The terms of the deal were undisclosed. The entire team of 12 at MediAngels is now part of 1mg.


This is the second acquisition for 1mg this year; in July, the Sequoia-backed company acquired Medd, a diagnostics and imaging tests marketplace.

Prashant Tandon, CEO 1mg said,

“Our consumers can now access a deep network of over 450 super specialists across India and the world, and we also get an entry into the corporate health space through this platform. We now offer a comprehensive suite of services to consumers as well as corporate customers which includes ePharmacy, eDiagnostics, eConsultations and Super Speciality Second Opinions as well.”

1mg, earlier called HealthkartPlus, the drug search business of Healthkart was rebranded and spun off into a separate entity as 1mg. The company operates an online marketplace for medicines apart from facilitating doctor’s appointment and diagnostic test booking.

MediAngels was founded in 2011 by Dr. Arbinder Singal and Dr. Debraj Shome. With more than 450 super specialist doctor strong team across 93 specialties, MediAngels has seen good number of cases in cardiology, cancers, neurosurgery, orthopedics and pediatric subspecialties and traction from both – metros and tier 2 cities.

Arbinder Singal, founder of MediAngels added,

“ Within the 1mg ecosystem, we plan to scale up second opinions and drive B2B engagements with more insurers and corporates. Our robust technology tools will help them optimise employee benefits spends on healthcare and to have a healthier workforce.”

About Author

Sangeeta Ghosh

Sangeeta is an engineering graduate and is passionate about painting and music. She is always blooming with new ideas and is a real go to person when you are searching for one. Exploring good dining places across the city is her favourite off-field indulgence. At KnowStartup, she is an integral part of the editorial team.

Leave A Reply